Medical Devices · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Integra Lifesciences Holdings Corp publishes a filing, an earnings call transcript or a press release.
Get IART alertsLea Knight is recorded as CFO at Integra Lifesciences Holdings Corp (IART). The newest filing on record that lists Lea Knight as CFO at Integra Lifesciences Holdings Corp (IART) is dated April 6, 2026. The proxy statement of Integra Lifesciences Holdings Corp reports total compensation of $2,882,994 for Lea Knight in fiscal 2025, including a base salary of $638,646. Disclosed compensation is on record for 3 fiscal years. Lea Knight has spoken on 12 earnings calls and 3 other investor events across 1 company, most recently for Integra Lifesciences Holdings Corp on September 9, 2026. Integra Lifesciences Holdings Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Integra Lifesciences Holdings Corp includes Dr. Stuart M. Essig (CEO), Mojdeh Poul (CEO and Board Member), Stuart M. Essig (CEO and Chairman) and 7 others.
“Let me take that, and I'll start with, first, I'll point to our performance in the first two quarters of this year.”
“I want to begin by thanking our team for their continued strong execution in the second quarter. Turning to slide five, I will cover our second quarter financial results.”
“And Matt, thank you for the opportunity to be here. We appreciate it. So certainly, Integra Life Sciences is a global medical technology company with leadership in both neurosurgery and regenerative medicine.”
“So as you mentioned last week, as part of our earnings, we announced the fact that Moshe Pohl and the board came to a mutual decision for her to step down as CEO, and now Seward occupies the position of both chairman and CEO.”
“I'd like to first thank our team for their contributions to our first quarter results. We delivered strong revenue and adjusted earnings per share in the quarter, reflecting solid product demand, improving supply execution and remediation, and the continued positive impact of our transformation.”
Start not stated–present
Last confirmed April 6, 2026
Medical Devices · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Integra Lifesciences Holdings Corp (IART) | Executive Vice President and Chief Financial Officer | $638,646 | $2,882,994 |
| 2024 | Integra Lifesciences Holdings Corp (IART) | Executive Vice President and Chief Financial Officer | $616,662 | $3,145,466 |
| 2023 | Integra Lifesciences Holdings Corp (IART) | Executive Vice President and Chief Financial Officer | $295,385 | $1,673,147 |